Literature DB >> 8560520

Visceral leishmaniasis: use of the polymerase chain reaction in an epidemiological study in Baringo District, Kenya.

K U Schaefer1, G J Schoone, G S Gachihi, A S Muller, P A Kager, S E Meredith.   

Abstract

The polymerase chain reaction was applied to capillary blood spots dried on filter paper from 20 parasitologically proved cases of visceral leishmaniasis (VL), 21 subclinical cases, and 11 healthy controls in a longitudinal study of anthroponotic VL in Baringo District, Kenya. Leishmania deoxyribonucleic acid (DNA) was detected 10.5 months before diagnosis and up to 3 years after diagnosis and apparently successful treatment. Subclinical cases can have detectable circulating parasite DNA in their blood. These findings may indicate that subclinical cases can be a reservoir and formerly treated VL patients can remain a reservoir for a long time. Xenodiagnosis should be performed on subclinical cases and former VL patients to establish their role in transmission of VL in Kenya.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560520     DOI: 10.1016/0035-9203(95)90081-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients.

Authors:  L Lachaud; J Dereure; E Chabbert; J Reynes; J M Mauboussin; E Oziol; J P Dedet; P Bastien
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.

Authors:  Z Rezaei; B Sarkari; M Dehghani; A Layegh Gigloo; M Afrashteh
Journal:  Parasitol Res       Date:  2018-06-02       Impact factor: 2.289

4.  Utility of filter paper for preserving insects, bacteria, and host reservoir DNA for molecular testing.

Authors:  F Karimian; Mm Sedaghat; Ma Oshaghi; F Mohtarami; A Sanei Dehkordi; M Koosha; S Akbari; Ss Hashemi-Aghdam
Journal:  Iran J Arthropod Borne Dis       Date:  2011-12-31

5.  Sero-prevalence of Leishmania donovani infection in labour migrants and entomological risk factors in extra-domestic habitats of Kafta-Humera lowlands - kala-azar endemic areas in the northwest Ethiopia.

Authors:  Wossenseged Lemma; Habte Tekie; Solomon Yared; Meshesha Balkew; Teshome Gebre-Michael; Alon Warburg; Asrat Hailu
Journal:  BMC Infect Dis       Date:  2015-02-26       Impact factor: 3.090

6.  Seroprevalence of Asymptomatic Leishmania donovani among Laborers and Associated Risk Factors in Agricultural Camps of West Armachiho District, Northwest Ethiopia: A Cross-Sectional Study.

Authors:  Animen Ayehu; Yibeltal Aschale; Wossenseged Lemma; Animut Alebel; Ligabaw Worku; Ayalew Jejaw; Abebe Genetu Bayih
Journal:  J Parasitol Res       Date:  2018-11-28

Review 7.  A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?

Authors:  Johan van Griensven; Ermias Diro; Rogelio Lopez-Velez; Koert Ritmeijer; Marleen Boelaert; Ed E Zijlstra; Asrat Hailu; Lutgarde Lynen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07

Review 8.  A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

Authors:  Waleed Al-Salem; Jennifer R Herricks; Peter J Hotez
Journal:  Parasit Vectors       Date:  2016-08-22       Impact factor: 3.876

9.  Asymptomatic Leishmania Infected Children: A Seroprevalence and Molecular Survey in a Rural Area of Fars Province, Southern Iran.

Authors:  Akram Layegh Gigloo; Bahador Sarkari; Zahra Rezaei; Gholam Reza Hatam; Mohammad Hassan Davami
Journal:  J Trop Med       Date:  2018-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.